Pfizer to settle Bextra, Celebrex claims for $894M

Related Products

• Healthcare Life Safety Compliance

  Learn Life Safety Code tips and interpretations for healthcare facilities with this in-depth monthly resource.

• Briefings on Infection Control

  Your facility's infection control and prevention initiatives are in the spotlight: Scrutiny from The Joint Commission, CDC...

• ePharm5 InDepth

  EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...

• Medical Environment Update

  Timely medical compliance news from OSHA, CDC, EPA, and other regulatory agencies!

• OSHA Regulatory Manual for Healthcare

  The OSHA Regulatory Manual for Healthcare is packed with clear, concise tips, tools, and strategies that are designed to...

Most Popular

Related Articles

• GSK settles Paxil suit

  GlaxoSmithKline (GSK) will pay $40 million to settle a class action lawsuit with 42,000 health plans that covered children...

• Eli Lilly to pay $62M for improperly marketing Zyprexa

  Eli Lilly agreed to pay $62 million to 32 states and the District of Columbia to resolve allegations it improperly marketed...

• Pfizer accused of suppressing Neurontin study

  Pfizer marketing executives allegedly knew Neurontin, an epilepsy drug, did not effectively treat other conditions and...

• Lilly nears federal Zyprexa settlement

  Eli Lilly’s total legal expenses for suits relating to its antipsychotic medication Zyprexa could soon top $2.6...

• Pfizer Bextra settlement could top $2B

  A $2.3 billion estimated settlement could eclipse Eli Lilly?s $1.4 billion payment to resolve allegations of off-label...